Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

August 2017; 3 (4) Clinical/Scientific NotesOpen Access

Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset

Mateja Smogavec, Jana Zschüntzsch, Wolfram Kress, Julia Mohr, Peter Hellen, Barbara Zoll, Silke Pauli, Jens Schmidt
First published July 10, 2017, DOI: https://doi.org/10.1212/NXG.0000000000000167
Mateja Smogavec
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Zschüntzsch
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfram Kress
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Mohr
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hellen
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Zoll
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silke Pauli
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Schmidt
From the Institute of Human Genetics (M.S., B.Z., S.P.), Department of Neurology (J.Z., J.S.), and Department of Neuroradiology (P.H.), University Medical Center Göttingen; Department of Human Genetics (W.K.), University of Würzburg; and CeGaT GmbH und Praxis für Humangenetik (J.M.), Tübingen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset
Mateja Smogavec, Jana Zschüntzsch, Wolfram Kress, Julia Mohr, Peter Hellen, Barbara Zoll, Silke Pauli, Jens Schmidt
Neurol Genet Aug 2017, 3 (4) e167; DOI: 10.1212/NXG.0000000000000167

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
694

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of childhood- or adult-onset inherited neuromuscular disorders, which are characterized by weakness and wasting of proximal limb and axial muscles. LGMDs are divided into 8 autosomal-dominant (LGMD1)1 and 25 autosomal-recessive (LGMD2) forms (omim.org/phenotypicSeries/PS253600). One autosomal-recessive form is the LGMD2M (new nomenclature: Muscular Dystrophy-Dystroglycanopathy, type C, 4, MDDGC4, MIM #611588), which is caused by homozygous or compound heterozygous mutations in the fukutin gene (FKTN; MIM #607440) on chromosome 9q31.2. The LGMD2M, as the clinical mild end of fukutin-related muscle dystrophy without mental retardation, is rare worldwide and described mostly in individuals of non-Japanese descent (table e-1 at Neurology.org/ng).2,–,5

Here, we report the second German case with an LGMD2M phenotype and describe 2 previously unreported mutations in the FKTN gene in a German female patient.

Clinical case presentation.

A 32-year-old female patient was admitted to our Neuromuscular Center. Written consent was obtained for the use of all clinical and diagnostic data. The patient was born to healthy nonconsanguineous parents. At the age of 7 years, cramping muscle pain, especially in the thighs, started and was accompanied by creatine kinase (CK) elevation. A muscle biopsy record described a chronic myopathic pattern and marked inflammation. The patient was treated with a corticosteroid, which profoundly reduced the CK level. In the following years, the patient developed a slowly progressive muscle weakness of both legs. At the age of 16 years, problems in climbing stairs and lifting heavy objects were noted. At the time of admission, the patient started to use a wheelchair for outdoor activities.

Neurologic examination revealed normal intellectual status, cranial nerve function, and sensorium. Inspection showed scapular winging, calf muscle enlargement, toe walking, and lumbar hyperlordosis (figure, A and D). We observed muscular atrophy with accentuation of the proximal lower extremities and reduced muscle strength. Gower and Trendelenburg signs were positive. Deep tendon reflexes were diminished. The patient also suffered from mild dysphagia and respiratory distress. EMG showed myopathic changes. Muscular MRI revealed a pronounced lipodystrophy of proximal upper and lower limb and limb-girdle muscles (figure, B, C, E, G, and H).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Clinical presentation and imaging findings in the patient

Clinical presentation: atrophy of the proximal muscles in the upper extremities. Note the scapula alata (A) and the characteristic symmetric hypertrophy of gastrocnemius muscles (D). Imaging findings: MRI of the upper extremity demonstrates a moderate atrophy of the rotator cuff and the deltoid muscle (B and C). MRI of the lower extremity shows a severe symmetric atrophy with fatty degeneration of musculature of both tights (E and F). The less atrophied sartorius and gracilis muscles depict a pronounced edema (G) and a strong gadolinium enhancement representing acute disease activity (H and I). B, C, E, and F: transverse T1-weighted images, G: coronal STIR sequence; H and I: transverse fat-saturated T1-weighted images postcontrast.

A multigene panel for LGMDs by next-generation sequencing (NGS) on genomic DNA isolated from a blood sample of our patient was performed. Coding and flanking sequences of all relevant genes were enriched using Agilent SureSelect technology. Massively parallel sequencing was performed using the HiSeq 2500 Sequencing platform from Illumina. Sanger sequencing was used for badly covered regions and validation of potentially pathogenic mutations.

In our patient, 2 novel missense mutations c.895A>C; p.Ser299Arg and c.1325A>G; p.Asn442Ser of the FKTN gene (NM_001079802.1) were found by NGS analysis and confirmed by Sanger sequencing. Both mutations disturb highly conserved positions in the fukutin protein. Several in silico prediction programs (MutationTaster, PolyPhen-2, SIFT) indicated that these mutations are most likely damaging. In Exome Aggregation Consortium (ExAC) and in Exome Server Browser, the variant c.895A>C was detected in heterozygous state only in one person, whereas the variant c.1325A>G had not been observed before.

With only one mutation c.1325A>G present in the father, a compound heterozygosity of the 2 mutations in our patient is strongly implied. Based on all information, we predict these 2 mutations as causative for the patients' disease.

Discussion.

Mutations in FKTN cause a wide clinical spectrum of myopathies: from severe congenital forms of muscular dystrophy with additional extramuscular symptoms to a milder form of LGMD2M, which is normally not associated with cognitive impairment.2 In the phenotypical spectrum of FKTN mutations, the classification from congenital muscular dystrophy (CMD) to LGMD2M was defined according to the onset of weakness.2 In practice, patients might display a phenotype well in between CMD and LGMD,2,6 pointing to an inherent difficulty of a strict classification. The phenotype of our patient is characterized by childhood onset, hypertrophy of calves, normal intelligence, and initial responsiveness to steroids.

The reduced ability of our patient to walk in her teens is in line with previous reports.7 In addition, we can provide clinical data of our patient until the age of 32 years. Our patient initially responded to steroid therapy, which might be explained by the profound inflammation in the muscle biopsy, comparable with the positive effect of steroids in Duchenne muscular dystrophy.

We show a rare case of LGMD2M and provide further insight into heterogeneity of phenotypes caused by mutations in FKTN and underline the importance of broad genetic assessment to provide correct diagnosis and to facilitate individual treatment in the future.

Footnotes

  • ↵* These authors contributed equally to this work as co–first authors.

  • ↵† These authors contributed equally to this work as co–last authors.

  • Supplemental data at Neurology.org/ng

  • Author contributions: Mateja Smogavec and Jana Zschüntzsch: case report study and concept and design. Wolfram Kress: analysis and interpretation of data and critical revision of manuscript. Julia Mohr: analysis and interpretation of data. Peter Hellen: interpretation of radiologic imaging. Barbara Zoll: critical revision of the manuscript. Silke Pauli and Jens Schmidt: case report study concept and critical revision of the manuscript.

  • Study funding: No targeted funding reported.

  • Disclosure: M. Smogavec reports no disclosures. J. Zschüntzsch has received travel funding/speaker honoraria from Biotest AG and Grifols. W. Kress reports no disclosures. J. Mohr has been an employee of CeGaT GmbH and Praxis für Humangenetik. P. Hellen, B. Zoll, and S. Pauli report no disclosures. J. Schmidt has served on scientific advisory boards for BioMarin and CSL Behring; has received travel funding/speaker honoraria from Bayer, Biogen, Biotest, CSL Behring, Grifols, Novartis, Octapharma, and VitalAire; has served on the editorial boards of BMC Neurology, American Journal of Neuroscience, Edorium Journal of Neurology, World Journal of Neurology, and Journal of Neuromuscular Diseases; has been a consultant for Novartis and CSL Behring; and has received research support from Biogen, CSL Behring, Novartis, Octapharma, Association francaise contre les myopathies, and Deutsche Gesellschaft für Muskelkranke. Go to Neurology.org/ng for full disclosure forms. The Article Processing Charge was funded by Institute of Human Genetics Goettingen.

  • Received February 8, 2017.
  • Accepted in final form April 28, 2017.
  • Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Nigro V,
    2. Savarese M
    . Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 2014;33:1–12.
    OpenUrlPubMed
  2. 2.↵
    1. Godfrey C,
    2. Clement E,
    3. Mein R, et al
    . Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007;130:2725–2735.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Vuillaumier-Barrot S,
    2. Quijano-Roy S,
    3. Bouchet-Seraphin C, et al
    . Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype. Neuromuscul Disord 2009;19:182–188.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Saredi S,
    2. Ruggieri A,
    3. Mottarelli E, et al
    . Fukutin gene mutations in an Italian patient with early onset muscular dystrophy but no central nervous system involvement. Muscle Nerve 2009;39:845–848.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Puckett RL,
    2. Moore SA,
    3. Winder TL, et al
    . Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromuscul Disord 2009;19:352–356.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ceyhan-Birsoy O,
    2. Talim B,
    3. Swanson LC, et al
    . Whole exome sequencing reveals DYSF, FKTN, and ISPD mutations in congenital muscular dystrophy without brain or eye involvement. J Neuromuscul Dis 2015;2:87–92.
    OpenUrlPubMed
  7. 7.↵
    1. Riisager M,
    2. Duno M,
    3. Hansen FJ,
    4. Krag TO,
    5. Vissing CR,
    6. Vissing J
    . A new mutation of the fukutin gene causing late-onset limb girdle muscular dystrophy. Neuromuscul Disord 2013;23:562–567.
    OpenUrlPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures

Topics Discussed

  • Muscle disease

Alert Me

  • Alert me when eletters are published
Advertisement
Neurology Genetics: 8 (4)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise